Bowel preparation before colonoscopy
Conditions
Interventions
Intervention group: use of toilet to take the "thinker" position to defecate
:Have the patient sit on the toilet with feet on a small bench, the upper body slightly arched forward, hands supporting the chin, and elbows on the knees.
Control group: use a toilet to remove the end sitting position to defecate:None
Sponsors
Fengdu People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Age 18~75 years old, gender is not limited; (2) Diagnosis of functional constipation, according to Roman IV diagnostic criteria; (3) Outpatients who have no contraindications to colonoscopy and require intestinal preparation for diagnostic colonoscopy; (4) The toilet used is a toilet, and it can be used together during intestinal preparation; (5) Patients who can receive 3L PEG intestinal preparation program and can tolerate it; (6) All completed the Constipation Severity Assessment Scale (CSS) before enrollment; (7) The American Society of Anesthesiologists (ASA) is graded as grade I~III; (8) Voluntarily participate in this clinical study, be able to cooperate with the completion of questionnaire surveys, and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients who are unable to cooperate in correcting defecation posture due to physical and age reasons, or who cannot use toilet seats and/or small benches and other defecation aids throughout the process of intestinal preparation; (2) Patients who have undergone colorectal surgery and have changed colorectal anatomy and are not suitable for using BBPS score; (3) Therapeutic or emergency colonoscopy, such as daytime polypectomy, emergency gastrointestinal bleeding, etc.; (4) Suffering from organic diseases that may cause constipation: such as metabolic diseases (diabetes, hypothyroidism, parathyroid disease, etc.), neurogenic diseases (Parkinson's, brain tumors, multiple sclerosis, etc.), colorectal primary diseases (highly suspected or confirmed colorectal malignant tumors, inflammatory bowel disease or intestinal tuberculosis, anorectal strictures or congenital malformations and other rectal and lesions), etc.; (5) Drug-induced constipation: mainly includes constipation induced by anticholinergic drugs, opioids, antidepressants, anticonvulsants, etc.; (6) Suffering from diseases that affect the conduct or results of the study: such as psychiatric diseases, spinal cord injury, intestinal obstruction or perforation, severe heart, lung, liver and kidney diseases, digestive system tumors or gastrointestinal surgery history; (7) pregnant or lactating women; (8) Those who are allergic to the drugs used in this study; (9) Patients with other conditions that the investigator believes are not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Boston Scale score;Detection rate of colorectal adenoma;Cecal intubation time;Colonoscopy withdrawal time;Blind rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of adverse events;The total number of defecation;The time of going to the toilet each time;The last fecal character;Patient tolerability and satisfaction; | — |
Countries
China
Contacts
Public ContactYu-ling Xiong
Fengdu People's Hospital
Outcome results
None listed